Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Sweden
  4. Nasdaq Stockholm
  5. Swedish Orphan Biovitrum AB (publ)
  6. Company
    SOBI   SE0000872095

SWEDISH ORPHAN BIOVITRUM AB (PUBL)

(SOBI)
  Report
Real-time Estimate Cboe Europe  -  10:23 2022-10-06 am EDT
221.45 SEK   -0.02%
09/30Sobi - New number of shares and votes in Swedish Orphan Biovitrum AB
AQ
09/30New number of shares and votes in Swedish Orphan Biovitrum AB (publ)
AQ
09/16ADC Therapeutics, Sobi Say CHMP Opinion Positive for Zynlonta for Relapsed or Refractory Diffuse Large B-cell Lymphoma
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Business Summary
Logo Swedish Orphan Biovitrum AB (publ)
Swedish Orphan Biovitrum publ AB is a Sweden-based pharmaceutical company. The Company develops, manufactures and sells medications within hemophilia, autoimmune diseases, metabolic diseases and cancer supportive care. The Company’s product portfolio is divided into three business segments: the Core Products segment offers pharmaceuticals within Inflammation area, and Genetics and metabolic therapeutic area; the Partner Products segment offers about 40 pharmaceuticals within hematology, oncology and emergency medicines, and the ReFacto Manufacturing segment. The Company has subsidiaries in Sweden, Denmark, Finland, Norway, United Kingdom and France, among others. On September 9, 2013, the Company acquired the full rights to develop and commercialize Kineret (anakinra) from Amgen, the biotechnology company based in the United States.

Number of employees : 1 559 people.
Sales per Business
20202021Delta
Hematology8 660.0056.7%8 536.0055% -1.43%
Immunology5 415.0035.5%5 780.0037.2% +6.74%
Specialty Care1 186.007.8%1 213.007.8% +2.28%
SEK in Million
Sales per region
20202021Delta
United States5 435.0035.6%6 054.0039% +11.39%
Europe1 055.006.9%3 295.0021.2% +212.32%
France4 400.0028.8%1 805.0011.6% -58.98%
Global1 301.008.5%1 251.008.1% -3.84%
Germany1 445.009.5%1 233.007.9% -14.67%
Rest of the World857.005.6%1 147.007.4% +33.84%
Sweden720.004.7%678.004.4% -5.83%
North America48.000.3%66.000.4% +37.5%
SEK in Million
Managers
Name Title Age Since
Guido Oelkers President & Chief Executive Officer 57 2017
Henrik Stenqvist Chief Financial Officer 54 2018
Sven Ullman Chief Medical Officer, Head-Research & Development 65 2022
Christine Wesström Head-Technical Operations 46 2010
Thomas Kudsk Larsen Head-Communication & Investor Relations 47 2021
Pablo de Mora, Dr. Head-Global Marketing & Access 53 2019
Philip Wood Vice President & Commercial Head-Haemotology 53 2013
Armin Reininger Head-Medical & Scientific Affairs 64 2017
Norbert Oppitz Head-International 54 -
Mahmood Ladha Head-Strategic Transformation Operations 57 -
Members of the board
Name Title Age Since
Sven Håkan Björklund Chairman 66 2016
Helena Ildiko Saxon Independent Director 51 2011
Matthew Gantz Independent Director 56 2012
Annette V. Clancy Independent Director 67 2014
Staffan Schüberg Independent Director 52 2020
Filippa Stenberg Independent Director - -
Bo Jesper Hansen, Dr. Deputy Chairman 63 2022
Pia Axelson Director 59 2019
Erika Husing Director 48 2020
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 307,114,495 178,464,186 58.1% 11,328,849 3.7% 57.8%
Stock B 0.1 1,621,178 0 0.0% 1,621,178 100.0%
Shareholders
NameEquities%
Investor AB (Investment Company) 107,594,165 35.0%
Fjärde AP-fonden 20,440,422 6.66%
Swedish Orphan Biovitrum AB (publ) 11,258,569 3.67%
Swedbank Robur Fonder AB 10,213,959 3.33%
Handelsbanken Fonder AB 8,963,688 2.92%
Norges Bank Investment Management 5,222,809 1.70%
The Vanguard Group, Inc. 4,694,352 1.53%
Amundi Asset Management SA (Investment Management) 4,667,063 1.52%
Schroder Investment Management Ltd. 4,520,988 1.47%
BlackRock Fund Advisors 4,224,015 1.38%
Holdings
NameEquities%Valuation
SWEDISH ORPHAN BIOVITRUM AB (PUBL) (SOBI) 11,258,569 3.67% 249,455,100 USD
Company contact information
Swedish Orphan Biovitrum AB
Tomtebodavägen 23A
Solna, Stockholm 112 76

Phone : +46.8.697.20.00
Fax : +46.8.697.23.30
Web : http://www.sobi.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Swedish Orphan Biovitrum AB (publ)